SUTRO BIOPHARMA, INC. (STRO) Operating margin 2016–2025
SUTRO BIOPHARMA, INC. (STRO) operating margin by fiscal year — reported operating income divided by reported revenue.
-154.5%FY2025 · since FY2016: 2.3% → -154.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -154.5% | +229.8 pp |
| FY2024 | -384.3% | -326.3 pp |
| FY2023 | -58.1% | +132.2 pp |
| FY2022 | -190.3% | -31.0 pp |
| FY2021 | -159.2% | +7.1 pp |
| FY2020 | -166.3% | -36.5 pp |
| FY2019 | -129.8% | -32.9 pp |
| FY2018 | -96.9% | -59.6 pp |
| FY2017 | -37.2% | -39.5 pp |
| FY2016 | 2.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice